Di Wang

Di Wang

Auto-generated profile, based on publicly available information

Di Wang

Zhejiang Key Laboratory of Precise Diagnosis and Treatment of Abdominal Infection, Sir Run Run Shaw Hospital, and Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, P.R. China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in Immunity
Verified
Journal Article
Closed access
CGChuansheng Guo
Chuansheng Guo
SXShujun Xie
Shujun Xie
ZCZhexu Chi
Zhexu Chi
JZJinhua Zhang
Jinhua Zhang
YLYangyang Liu
Yangyang Liu
DWDi Wang
Di Wang

1 September 2019 in Molecular Cell
Verified
Journal Article
Closed access
WYWeiwei Yu
Weiwei Yu
ZWZhen Wang
Zhen Wang
KZKailian Zhang
Kailian Zhang
ZCZhexu Chi
Zhexu Chi
TXTing Xu
Ting Xu
DWDi Wang
Di Wang

1 November 2018 in Immunity
Verified
Journal Article
Closed access
CGChuansheng Guo
Chuansheng Guo
ZCZhexu Chi
Zhexu Chi
DJDanlu Jiang
Danlu Jiang
TXTing Xu
Ting Xu
WYWeiwei Yu
Weiwei Yu
DWDi Wang
Di Wang

15 February 2021 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
JHJinchao Hou
Jinchao Hou
JZJue Zhang
Jue Zhang
PCPing Cui
Ping Cui
YZYingyue Zhou
Yingyue Zhou
CLCan Liu
Can Liu
XFXiangming Fang
Xiangming Fang
Sepsis is a leading cause of death in critical illness, and its pathophysiology varies depending on preexisting medical conditions. Here we identified nonalcoholic fatty liver disease (NAFLD) as an independent risk factor for sepsis in a large clinical cohort and showed a link between mortality in NAFLD-associated sepsis and hepatic mitochondrial and energetic metabolism dysfunction. Using in vivo and in vitro models of liver lipid overload, we discovered a metabolic coordination between hepatocyte mitochondria and liver macrophages that express triggering receptor expressed on myeloid cells-2 (TREM2). Trem2-deficient macrophages released exosomes that impaired hepatocytic mitochondrial structure and energy supply because of their high content of miR-106b-5p, which blocks Mitofusin 2 (Mfn2). In a mouse model of NAFLD-associated sepsis, TREM2 deficiency accelerated the initial progression of NAFLD and subsequent susceptibility to sepsis. Conversely, overexpression of TREM2 in liver macrophages improved hepatic energy supply and sepsis outcome. This study demonstrates that NAFLD is a risk factor for sepsis, providing a basis for precision treatment, and identifies hepatocyte-macrophage metabolic coordination and TREM2 as potential targets for future clinical trials.

7 December 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
YGYuxian Guo
Yuxian Guo
YLYaru Liu
Yaru Liu
SZShihao Zhao
Shihao Zhao
WXWangting Xu
Wangting Xu
YLYiqing Li
Yiqing Li
XZXue Zhang
Xue Zhang
Oxidative stress contributes to the pathogenesis of acute lung injury. Protein S-glutathionylation plays an important role in cellular antioxidant defense. Here we report that the expression of deglutathionylation enzyme Grx1 is decreased in the lungs of acute lung injury mice. The acute lung injury induced by hyperoxia or LPS is significantly relieved in Grx1 KO and Grx1fl/flLysMcremice, confirming the protective role of Grx1-regulated S-glutathionylation in macrophages. Using a quantitative redox proteomics approach, we show that FABP5 is susceptible to S-glutathionylation under oxidative conditions. S-glutathionylation of Cys127 in FABP5 promotes its fatty acid binding ability and nuclear translocation. Further results indicate S-glutathionylation promotes the interaction of FABP5 and PPARβ/δ, activates PPARβ/δ target genes and suppresses the LPS-induced inflammation in macrophages. Our study reveals a molecular mechanism through which FABP5 S-glutathionylation regulates macrophage inflammation in the pathogenesis of acute lung injury.

11 January 2021 in Gut
Verified
Journal Article
Open access
PDF file
JLJiang Li
Jiang Li
XLXi Liang
Xi Liang
JJJing Jiang
Jing Jiang
LYLingling Yang
Lingling Yang
JXJiaojiao Xin
Jiaojiao Xin
Jun LiJun Li
Jun Li
Objective Hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) pathophysiology remains unclear. This study aims to characterise the molecular basis of HBV-ACLF using transcriptomics. Methods Four hundred subjects with HBV-ACLF, acute-on-chronic hepatic dysfunction (ACHD), liver cirrhosis (LC) or chronic hepatitis B (CHB) and normal controls (NC) from a prospective multicentre cohort were studied, and 65 subjects (ACLF, 20; ACHD, 10; LC, 10; CHB, 10; NC, 15) among them underwent mRNA sequencing using peripheral blood mononuclear cells (PBMCs). Results The functional synergy analysis focusing on seven bioprocesses related to the PBMC response and the top 500 differentially expressed genes (DEGs) showed that viral processes were associated with all disease stages. Immune dysregulation, as the most prominent change and disorder triggered by HBV exacerbation, drove CHB or LC to ACHD and ACLF. Metabolic disruption was significant in ACHD and severe in ACLF. The analysis of 62 overlapping DEGs further linked the HBV-based immune-metabolism disorder to ACLF progression. The signatures of interferon-related, neutrophil-related and monocyte-related pathways related to the innate immune response were significantly upregulated. Signatures linked to the adaptive immune response were downregulated. Disruptions of lipid and fatty acid metabolism were observed during ACLF development. External validation of four DEGs underlying the aforementioned molecular mechanism in patients and experimental rats confirmed their specificity and potential as biomarkers for HBV-ACLF pathogenesis. Conclusions This study highlights immune-metabolism disorder triggered by HBV exacerbation as a potential mechanism of HBV-ACLF and may indicate a novel diagnostic and treatment target to reduce HBV-ACLF-related mortality.